πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9889182

Assisted enzyme replacement therapy

The Regents of the University of California Β· Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9889071

Calcium sulfate-resin hybrid materials and methods of using and making the same

The Regents of the University of California Β· Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9885014

Re-conditioned serum-free culture medium composition obtained by culturing mammalian cells

The Regents of the University of California Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9884070

Selective high-affinity polydentate ligands and methods of making such

The Regents of the University of California Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9878137

Bioactive agent delivery devices and methods of making and using the same

The Regents of the University of California Β· Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9878033

Immunogenic peptides for treatment of herpes simplex virus infection and conditions

The Regents of the University of California Β· Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9878006

Treatment of obesity and obesity related disorders by pharmalogical targeting of Kv1.3 pot

The Regents of the University of California Β· Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9873718

Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeu

The Regents of the University of California Β· Granted Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9868961

Methods and compositions for localized secretion of anti-CTLA-4 antibodies

The Regents of the University of California Β· Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9867845

Vectors for delivery of agents across biological membranes

The Regents of the University of California Β· Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9867778

Controlled release antimicrobial compositions and methods for the treatment of otic disord

The Regents of the University of California Β· Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9862693

Compounds and methods of treating cancer

The Regents of the University of California Β· Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9862684

Modulation of K2P channels

The Regents of the University of California Β· Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856539

Adeno-associated virus virions with variant capsid and methods of use thereof

The Regents of the University of California Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856283

Thiosaccharide mucolytic agents

The Regents of the University of California Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856273

ETP derivatives

The Regents of the University of California Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9855368

Bone morphogenic protein binding peptide

The Regents of the University of California Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9848853

System, method and devices for tissue-based diagnosis

The Regents of the University of California Β· Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9850207

Substituted piperidines as soluble epdxide hydrolase inhibitors

The Regents of the University of California Β· Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9845357

Integrin Ξ±vΞ²8 neutralizing antibody

The Regents of the University of California Β· Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9845237

Supramolecular approach for preparation of size controllable nanoparticles

The Regents of the University of California Β· Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9844657

Compositions comprising nanostructures for cell, tissue and artificial organ growth, and m

The Regents of the University of California Β· Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9844656

Localization of agents at a target site with a composition and an energy source

The Regents of the University of California Β· Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9840559

Anti-CD83 antibodies and use thereof

The Regents of the University of California Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted